Advertisement

Topics

Irritable Bowel Syndrome IBS Epidemiology Forecast to 2027 [Report Updated: 14022018] Prices from USD $3250

01:58 EDT 14 Mar 2018 | BioPortfolio Reports

DelveInsight's "Irritable Bowel Syndrome IBS Epidemiology Forecast, 2027 report provides a comprehensive analysis of the Irritable Bowel Syndrome IBS epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 20162027.


Markets Covered

United States

EU5 Germany, France, Italy, Spain, and the United Kingdom

Japan


Study Period: 20162027


Irritable Bowel Syndrome IBS Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Irritable Bowel Syndrome IBS in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Irritable Bowel Syndrome IBS outlook. It also includes the explanation of changing trends of epidemiology outlining the Irritable Bowel Syndrome IBS scenario.


Irritable Bowel Syndrome IBS Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as agespecific, typespecific, subtype specific, genderspecific etc., thus providing an indepth and highquality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Irritable Bowel Syndrome IBS thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.


Report Scope

The report covers detailed overview of Irritable Bowel Syndrome IBS explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 Germany, Spain, France, Italy, UK Japan

The Irritable Bowel Syndrome IBS Report assesses the disease risk and burden and highlights the unmet needs

It also helps to recognize the growth opportunities in the 7MM with respect to the patient population


Key strengths

10 Year Forecast

7MM Coverage

Total Cases in Irritable Bowel Syndrome IBS


Key assessments

Patient Segmentation in Irritable Bowel Syndrome IBS

Irritable Bowel Syndrome IBS Risk Burden

Factors driving growth in a specific Irritable Bowel Syndrome IBS patient population

Original Article: Irritable Bowel Syndrome IBS Epidemiology Forecast to 2027 [Report Updated: 14022018] Prices from USD $3250

NEXT ARTICLE

More From BioPortfolio on "Irritable Bowel Syndrome IBS Epidemiology Forecast to 2027 [Report Updated: 14022018] Prices from USD $3250"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Irritable Bowel Syndrome IBS
Irritable bowel syndrome (IBS) is a common but poorly understood chronic (long-term) condition where the normal functions of the bowel are disrupted. Symptoms of IBS include abdominal pain or discomfort, changes in bowel habits and bloated feelings. ...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...